Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT

Summit Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-221.31M -614.93M -78.78M -88.6M
Depreciation & Amortization
89K 2.05M 2.51M 2.46M
Stock-Based Compensation
50.98M 14.11M 9.88M 9.47M
Other Working Capital
12.93M -9.16M 11.77M -813K
Other Non-Cash Items
12.66M 524.38M 14.12M 497K
Deferred Income Tax
n/a n/a n/a 326K
Change in Working Capital
15.48M -2.37M 8.62M -67K
Operating Cash Flow
-142.11M -76.76M -41.58M -72.59M
Capital Expenditures
-139K -128K -624K -306K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-680.03M -321.02M n/a n/a
Sales Maturities Of Investments
489.84M 208.16M n/a n/a
Other Investing Acitivies
-15.01M -474.79M -600 n/a
Investing Cash Flow
-205.34M -587.77M -624K -306K
Debt Repayment
-100M -24.69M 520M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.33M 106.2M 100.24M 2.92M
Financial Cash Flow
381.23M 86.51M 620.24M 77.92M
Net Cash Flow
33.76M -577.18M 576.82M 5.37M
Free Cash Flow
-142.25M -76.89M -42.21M -72.89M